Straumann Diversifying?
Last week, Straumann, a global leader in implant dentistry and oral tissue regeneration, announced the acquisition of etkon, a privately-owned company in conventional and implant-based tooth restoration using CAD/CAM technology, for approximately EUR $100 million.
What is the rationale behind this deal? Straumann already has a growing presence in the CAD-CAM implant prosthetic arena with its individualized titanium and ceramic abutment service CARES, so why add on etkon, which has a growing presence in conventional tooth restoration, as opposed to just dental implant restoration? Is it possible that the increasing competition in the dental implant industry has caused Straumann to look to other areas for growth or is etkon merely a platform for the company to further increase the market penetration of its implant and regeneration products?
Straumann’s President and CEO Gilbert Achermann, had this to say about the purchase of etkon:
“We believe that future success in the tooth restoration industry will be increasingly driven by CAD-CAM prosthetics. etkon gives us an immediate sizeable presence in this area and makes us the only company in the dental sector that offers surgical, restorative and regenerative solutions – from bone augmentation and tissue regeneration, through implants and prosthetics, to individualized crowns and bridges. Our two companies are a superb fit – not just in terms of products and services but also with regard to company culture.â€
What are your thoughts?